Crosstalk between Peroxisome Proliferator-Activated Receptors and Toll-Like Receptors: A Systematic Review

(2019) Crosstalk between Peroxisome Proliferator-Activated Receptors and Toll-Like Receptors: A Systematic Review. Advanced Pharmaceutical Bulletin. pp. 12-21. ISSN 2228-5881

[img]
Preview
Text
10342.pdf

Download (634kB) | Preview

Abstract

As one of the four major families of pattern recognition receptors (PRRs), toll like receptors (TLRs) are crucial and important components of the innate immune system. Peroxisome proliferator-activated receptors (PPARs) with three isoforms are transcription factors classified as a subfamily of nuclear receptor proteins, and are of significant regulatory activity in cellular differentiation, development, metabolism, and tumorigenesis. It is well established that PPARs agonists display anti-inflammatory effects through inhibition of the nuclear factor-kappa B (NF-kappa B) pathway, a key regulator of immune and inflammatory responses, in a sense that TLRs signaling pathways are mainly toward activation of NF-kappa B. Through a systematic review of previous studies, we aimed to address and clarify the reciprocal interaction between TLRs and PPARs in hope to find alternative therapeutic approaches for inflammatory diseases. Among the available scientific database, 31 articles were selected for this review. A comprehensive review of this database confirms the presence of a cross-talk between PPARs and TLRs, indicating that not only PPARs stimulation may affect the expression level of TLRs via several mechanisms leading to modulating TLRs activities, but also TLRs have the potential to moderate the expression of PPARs. We, therefore, conclude that, as a key regulator of the innate immune system, the interaction between PPARs and TLRs is a potential therapeutic target in disease treatment.

Item Type: Article
Keywords: peroxisome proliferator-activated receptor toll-like receptor interaction crosstalk gamma agonist rosiglitazone lps-induced inflammation nf-kappa-b ppar-gamma nuclear receptors epithelial-cells cancer-cells map kinase expression pioglitazone
Divisions: Cardiovascular Research Institute > Applied Physiology Research Center
Cardiovascular Research Institute > Isfahan Cardiovascular Research Center
Page Range: pp. 12-21
Journal or Publication Title: Advanced Pharmaceutical Bulletin
Journal Index: ISI
Volume: 9
Number: 1
Identification Number: https://doi.org/10.15171/apb.2019.003
ISSN: 2228-5881
Depositing User: Zahra Otroj
URI: http://eprints.mui.ac.ir/id/eprint/10342

Actions (login required)

View Item View Item